leisure time -WSS

leisure time

author：fashion 2025-08-04 12:35:58 - browse：559

An army of wooden figures under blue and pink lighting — biotech coverage from STAT — Adobe

In an abrupt change of course from plans earlier in the month, at-home test maker Cue Health is laying off all of its employees and shutting down as of Friday, May 24.

The company, which grew to prominence during the Covid-19 pandemic as the maker of one of the only molecular at-home tests for the virus, has been teetering on the edge of insolvency for months. The shutdown, first reported by the San Diego Union-Tribune, comes just over a week after the FDA warned consumers not to use Cue’s only FDA-authorized product, a Covid-19 test kit.

Cue had previously notified 49% of its workers on May 1 that they would be laid off from the company, effective July 1. But in a WARN notice filed with California state regulators on May 20, chief human resources officer Allison Blackwell said that due to the “fluid nature of this situation,” all U.S. employees who had not already received notice of termination would be receiving one. All employees will receive their last paychecks on May 24, the notice said.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： White House pharmacy plagued with problems, investigation finds

Wikipedia

WSS

Venture capital firm's plans to take over Akron hospital face hurdles

Pancreatic cancer early detection could be helped by AI

Bernie Sanders is gearing up to subpoena pharma CEOs

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

Why Charlie Gard's case is so disturbing to Americans

Stroke deaths set to near 10 million globally by 2050

knowledge

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

hotspot

The cancer drug shortage isn’t new — and neither are the solutions

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

Peter Hotez and the public health issue of online harassment

Investment in vaccine development is lagging, report finds

After affirmative action ruling, medical educators look to 'holistic review'

A Q&A with the global head of Boehringer Ingelheim's innovation unit

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

The Affordable Care Act has saved billions in health care costs

Duchenne breakthrough therapy leaves behind pioneering families

Venture capital firm's plans to take over Akron hospital face hurdles

focus

Phenylephrine and the overlooked value of the placebo effect

Why Charlie Gard's case is so disturbing to Americans

A Q&A with the global head of Boehringer Ingelheim's innovation unit

Merck CEO won’t testify in Senate, citing no expertise in drug prices

10 reasons why health care startups fail

A Q&A with the global head of Boehringer Ingelheim's innovation unit

leisure time

hotspot

Wikipedia

hotspot